Demographics, disease, and transplant characteristics
| Variable . | N (%) or median (range) . | ||
|---|---|---|---|
| RIC (n = 19) . | MAC (n = 19) . | All (n = 38) . | |
| Sex | |||
| Female | 8 (42) | 11 (58) | 19 (50) |
| Male | 11 (58) | 8 (42) | 19 (50) |
| Race | |||
| White | 12 (63) | 12 (63) | 24 (63) |
| Asian | 4 (21) | 4 (21) | 8 (21) |
| Black | 2 (11) | 2 (11) | 4 (11) |
| Unknown | 1 (5) | 1 (5) | 2 (5) |
| Ethnicity | |||
| Hispanic | 3 (16) | 8 (42) | 11 (29) |
| Non-Hispanic | 15 (79) | 11 (58) | 26 (68) |
| Unknown | 1 (5) | 0 (0) | 1 (3) |
| Patient’s age at HCT (y) | 63 (33-72) | 44 (21-57) | 53 (21-72) |
| Primary disease | |||
| AML | 5 (26) | 12 (64) | 17 (45) |
| ALL | 3 (16) | 5 (26) | 8 (21) |
| MDS | 5 (26) | 1 (5) | 6 (16) |
| NHL | 3 (16) | 0 (0) | 3 (8) |
| CML | 2 (11) | 1 (5) | 3 (8) |
| CLL | 1 (5) | 0 (0) | 1 (2) |
| HCT comorbidity index | 3 (0-6) | 2 (0-6) | 2 (0-6) |
| 0 | 1 (5) | 5 (26) | 6 (16) |
| 1-2 | 8 (42) | 7 (37) | 15 (39) |
| >2 | 10 (53) | 7 (37) | 17 (45) |
| DRI | |||
| Low | 3 (16) | 0 (0) | 3 (8) |
| Intermediate | 8 (42) | 14 (74) | 22 (58) |
| High | 5 (26) | 5 (26) | 10 (26) |
| Very high | 3 (16) | 0 (0) | 3 (8) |
| Sex donor/recipient | |||
| Female/male | 4 (21) | 0 (0) | 4 (11) |
| Others | 15 (79) | 19 (100) | 34 (89) |
| Donor age at HCT (y) | 35 (24-53) | 29 (19-48) | 32 (19-53) |
| Patient CMV status | |||
| Negative | 3 (16) | 5 (26) | 8 (21) |
| Positive | 16 (84) | 14 (74) | 30 (79) |
| CD34+ dose (106 cells/kg) | 5.28 (2.39-9.35) | 6.28 (3.53-9.04) | 5.45 (2.39-9.35) |
| Number of mismatches | 3 (1-4) | 2 (1-4) | 2 (1-4) |
| HLA class I (A B C) | |||
| Matched | 3 (16) | 2 (11) | 5 (13) |
| Mismatched (≥1) | 16 (84) | 17 (89) | 33 (87) |
| HLA class II (DR DQ DP) | |||
| Matched | 3 (16) | 5 (26) | 8 (21) |
| Mismatched (≥1) | 16 (84) | 14 (74) | 30 (79) |
| HLA DQ | |||
| Matched | 18 (95) | 18 (95) | 36 (95) |
| Mismatched (≥1) | 1 (5) | 1 (5) | 2 (5) |
| HLA DP | |||
| Matched | 4 (21) | 6 (32) | 10 (26) |
| Mismatched (≥1) | 15 (79) | 13 (68) | 28 (74) |
| Variable . | N (%) or median (range) . | ||
|---|---|---|---|
| RIC (n = 19) . | MAC (n = 19) . | All (n = 38) . | |
| Sex | |||
| Female | 8 (42) | 11 (58) | 19 (50) |
| Male | 11 (58) | 8 (42) | 19 (50) |
| Race | |||
| White | 12 (63) | 12 (63) | 24 (63) |
| Asian | 4 (21) | 4 (21) | 8 (21) |
| Black | 2 (11) | 2 (11) | 4 (11) |
| Unknown | 1 (5) | 1 (5) | 2 (5) |
| Ethnicity | |||
| Hispanic | 3 (16) | 8 (42) | 11 (29) |
| Non-Hispanic | 15 (79) | 11 (58) | 26 (68) |
| Unknown | 1 (5) | 0 (0) | 1 (3) |
| Patient’s age at HCT (y) | 63 (33-72) | 44 (21-57) | 53 (21-72) |
| Primary disease | |||
| AML | 5 (26) | 12 (64) | 17 (45) |
| ALL | 3 (16) | 5 (26) | 8 (21) |
| MDS | 5 (26) | 1 (5) | 6 (16) |
| NHL | 3 (16) | 0 (0) | 3 (8) |
| CML | 2 (11) | 1 (5) | 3 (8) |
| CLL | 1 (5) | 0 (0) | 1 (2) |
| HCT comorbidity index | 3 (0-6) | 2 (0-6) | 2 (0-6) |
| 0 | 1 (5) | 5 (26) | 6 (16) |
| 1-2 | 8 (42) | 7 (37) | 15 (39) |
| >2 | 10 (53) | 7 (37) | 17 (45) |
| DRI | |||
| Low | 3 (16) | 0 (0) | 3 (8) |
| Intermediate | 8 (42) | 14 (74) | 22 (58) |
| High | 5 (26) | 5 (26) | 10 (26) |
| Very high | 3 (16) | 0 (0) | 3 (8) |
| Sex donor/recipient | |||
| Female/male | 4 (21) | 0 (0) | 4 (11) |
| Others | 15 (79) | 19 (100) | 34 (89) |
| Donor age at HCT (y) | 35 (24-53) | 29 (19-48) | 32 (19-53) |
| Patient CMV status | |||
| Negative | 3 (16) | 5 (26) | 8 (21) |
| Positive | 16 (84) | 14 (74) | 30 (79) |
| CD34+ dose (106 cells/kg) | 5.28 (2.39-9.35) | 6.28 (3.53-9.04) | 5.45 (2.39-9.35) |
| Number of mismatches | 3 (1-4) | 2 (1-4) | 2 (1-4) |
| HLA class I (A B C) | |||
| Matched | 3 (16) | 2 (11) | 5 (13) |
| Mismatched (≥1) | 16 (84) | 17 (89) | 33 (87) |
| HLA class II (DR DQ DP) | |||
| Matched | 3 (16) | 5 (26) | 8 (21) |
| Mismatched (≥1) | 16 (84) | 14 (74) | 30 (79) |
| HLA DQ | |||
| Matched | 18 (95) | 18 (95) | 36 (95) |
| Mismatched (≥1) | 1 (5) | 1 (5) | 2 (5) |
| HLA DP | |||
| Matched | 4 (21) | 6 (32) | 10 (26) |
| Mismatched (≥1) | 15 (79) | 13 (68) | 28 (74) |